FATE THERAPEUTICS INC — Director's Dealing 2013

Oct 1, 2013

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: FATE THERAPEUTICS INC (FATE)
CIK: 0001434316
Period of Report: 2013-09-30

Reporting Person: Enyedy Mark J (Director)

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Stock Option (right to buy)	$1.37	2022-07-23	Common Stock (30769)		Direct

Footnotes

F1: The shares subject to this option shall vest and become exercisable at the rate of 1/4th of the shares on July 24, 2013 and 1/48th of the shares each month thereafter such that this option is fully exercisable on July 24, 2016.